Cargando…
AI-supported modified risk staging for multiple myeloma cancer useful in real-world scenario
INTRODUCTION: : An efficient readily employable risk prognostication method is desirable for MM in settings where genomics tests cannot be performed owing to geographical/economical constraints. In this work, a new Modified Risk Staging (MRS) has been proposed for newly diagnosed Multiple Myeloma (N...
Autores principales: | Farswan, Akanksha, Gupta, Anubha, Gupta, Ritu, Hazra, Saswati, Khan, Sadaf, Kumar, Lalit, Sharma, Atul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278429/ https://www.ncbi.nlm.nih.gov/pubmed/34247136 http://dx.doi.org/10.1016/j.tranon.2021.101157 |
Ejemplares similares
-
Does Ethnicity Matter in Multiple Myeloma Risk Prediction in the Era of Genomics and Novel Agents? Evidence From Real-World Data
por: Farswan, Akanksha, et al.
Publicado: (2021) -
Imputation of Gene Expression Data in Blood Cancer and Its Significance in Inferring Biological Pathways
por: Farswan, Akanksha, et al.
Publicado: (2020) -
Comment on: AI-supported modified risk staging for multiple myeloma cancer useful in real-world scenario
por: Khalil, Rania M., et al.
Publicado: (2021) -
Correlation of changes in subclonal architecture with progression in the MMRF CoMMpass study
por: Kaur, Gurvinder, et al.
Publicado: (2022) -
Chronic lymphocytic leukemia with deletion 17p: An Indian scenario
por: Gogia, Ajay, et al.
Publicado: (2019)